Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI® IV in China and a Co-Detailing collaboration in Shanghai

9 May 2019

Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association

8 May 2019

On 15 May 2019 Farma Industria Ticino will be at the University Hospital Center (CHUV) in Lausanne looking for talents

29 April 2019

Helsinn Supports Local Art Exhibition, ‘Lugano: Reflections of Light’ by Helidon Xhixha, curated by Eike D. Schmidt

19 April 2019

CSC Pharmaceuticals announces the launch of the innovative migraine and pain treatment developed by APR Applied Pharma Research

3 April 2019

Augusto Mitidieri Most Influential CEO of the Year 2018 – Europe

1 April 2019

Rare Diseases: PKU GOLIKE® debuts in Germany

21 March 2019

Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced

20 March 2019

Helsinn initiates two new global Phase III studies with anamorelin

7 March 2019

Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology

27 February 2019